{"id":547838,"date":"2026-09-01T15:06:30","date_gmt":"2026-09-01T15:06:30","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/547838\/microcaps-gpro-flye-hkpd-vivs-to-watch-now.html"},"modified":"2026-09-01T15:06:30","modified_gmt":"2026-09-01T15:06:30","slug":"microcaps-gpro-flye-hkpd-vivs-to-watch-now","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/547838\/microcaps-gpro-flye-hkpd-vivs-to-watch-now.html","title":{"rendered":"Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now"},"content":{"rendered":"<div style=\"float:right;width:250px;padding:8px 10px 10px 10px\"><a rel=\"nofollow noopener\" href=\"https:\/\/www.abnewswire.com\/upload\/2026\/09\/1788275241.jpg\" style=\"border:none !important\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-29\" title=\"Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/09\/1788275241.jpg\" alt=\"Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now\" width=\"225\" height=\"174\" \/><\/a><\/div>\n<p style=\"text-align: justify\"><strong>NEW YORK, September 1, 2026<\/strong> &mdash; Micro-cap and emerging-growth stocks <strong>GoPro, Inc. (NASDAQ: GPRO), Fly-E Group, Inc. (NASDAQ: FLYE), Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD) and VivoSim Labs, Inc. (NASDAQ: VIVS)<\/strong> are drawing investor attention across AI infrastructure, electric mobility, pharmaceutical supply chains and AI-powered drug development.<\/p>\n<p style=\"text-align: justify\"><strong>GoPro, Inc. (NASDAQ: GPRO)<\/strong> and privately held optical-photonics company <strong>Starman Optical, Inc.<\/strong> announced a definitive merger agreement that could significantly broaden GoPro&#8217;s business beyond consumer cameras. Under the proposed transaction, GoPro shareholders are expected to receive an aggregate <strong>$285 million in cash, or approximately $1.14 per share<\/strong>, subject to adjustment, while retaining approximately <strong>10% ownership of the combined company<\/strong>. Starman&#8217;s U.S.-made optical transceivers are expected to expand GoPro&#8217;s exposure to <strong>AI data centers, government, defense and aerospace markets<\/strong>, while GoPro is expected to remain publicly listed on Nasdaq.<\/p>\n<p style=\"text-align: justify\"><strong>Fly-E Group, Inc. (NASDAQ: FLYE)<\/strong> is an electric-vehicle company focused on designing, selling and renting <strong>electric motorcycles, e-bikes and related electric mobility products<\/strong> under the Fly E-Bike brand. Fly-E reported approximately <strong>$19.1 million in fiscal 2026 net revenue<\/strong>, including significant growth in its wholesale and rental businesses, as it continues targeting demand for urban electric transportation.<\/p>\n<p style=\"text-align: justify\"><strong>Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD)<\/strong> operates in the cross-border OTC pharmaceutical market through two primary businesses: <strong>e-commerce pharmaceutical supply-chain services<\/strong> through Joint Cross Border Logistics Company Limited and <strong>OTC pharmaceutical procurement and distribution<\/strong> through V-Alliance Technology Supplies Limited. Its operations connect pharmaceutical suppliers, logistics providers and merchants serving China&#8217;s growing cross-border e-commerce market.<\/p>\n<p style=\"text-align: justify\"><strong>VivoSim Labs, Inc. (NASDAQ: VIVS)<\/strong> uses <strong>NAMkind&trade; 3D human liver and intestinal models with AI-powered predictive toxicology<\/strong> to help pharmaceutical companies identify stronger drug candidates earlier, addressing a development process where <strong>5,000&ndash;10,000 compounds may ultimately yield just one approved drug<\/strong>. VivoSim is also developing a <strong>rat liver model to complement its NAMkind&trade; human liver platform<\/strong>, enabling drug developers to better compare animal and human toxicity signals and identify potential human toxicity that may not appear in animal studies. The company recently reported approximately <strong>$10.1 million in cash<\/strong>, supported in part by a <strong>$5 million milestone payment from Eli Lilly and Company (NYSE: LLY)<\/strong> related to a previously divested drug program.<\/p>\n<p style=\"text-align: justify\">Together, <strong>GPRO, FLYE, HKPD and VIVS<\/strong> give micro-cap investors exposure to four distinct developing themes: <strong>AI data-center optics, electric mobility, pharmaceutical e-commerce and AI-enabled human drug testing<\/strong>.<\/p>\n<p style=\"text-align: justify\">About the Companies<\/p>\n<p style=\"text-align: justify\"><strong>GoPro, Inc. (NASDAQ: GPRO)<\/strong> develops cameras, imaging technologies, software and subscription services and, through its proposed combination with Starman Optical, is seeking to expand into optical technologies serving AI infrastructure and other strategic markets.<\/p>\n<p style=\"text-align: justify\"><strong>Fly-E Group, Inc. (NASDAQ: FLYE)<\/strong> designs, sells and rents electric motorcycles, e-bikes and related electric mobility products under the Fly E-Bike brand.<\/p>\n<p style=\"text-align: justify\"><strong>Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD)<\/strong> provides cross-border OTC pharmaceutical supply-chain, procurement and distribution services primarily through its Hong Kong subsidiaries.<\/p>\n<p style=\"text-align: justify\"><strong>VivoSim Labs, Inc. (NASDAQ: VIVS)<\/strong> provides pharmaceutical and biotechnology companies with <strong>NAMkind&trade; 3D human liver and intestinal models and AI-powered predictive toxicology<\/strong> designed to support drug-development decisions.<\/p>\n<p style=\"text-align: justify\">About The Street Reports<\/p>\n<p style=\"text-align: justify\"><strong>The Street Reports (TSR)<\/strong> a financial media platform focused on emerging-growth, small-cap, micro-cap and nano-cap companies. The Street Reports publishes and distributes market-focused content across financial news, media and digital channels, providing companies with expanded visibility and exposure to a broad audience of readers and market participants.<\/p>\n<p style=\"text-align: justify\">&nbsp;<\/p>\n<p style=\"text-align: justify\">Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions &amp; quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor&#8217;s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.&#8221;TSR&#8221; is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. &#8220;TSR&#8221; authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. &#8220;TSR&#8221; has not been compensated to produce content related to &#8220;Any Companies&#8221; appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.<\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/thestreetreports.com_113087.html\">The Street Reports<\/a><br \/><strong>Contact Person:<\/strong> Editor<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=microcaps-gpro-flye-hkpd-vivs-to-watch-now\">Send Email<\/a><br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"http:\/\/www.thestreetreports.com\" target=\"_blank\">http:\/\/www.thestreetreports.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=microcaps-gpro-flye-hkpd-vivs-to-watch-now\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, September 1, 2026 &mdash; Micro-cap and emerging-growth stocks GoPro, Inc. (NASDAQ: GPRO), Fly-E Group, Inc. (NASDAQ: FLYE), Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD) and VivoSim Labs, Inc. (NASDAQ:<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/547838"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=547838"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/547838\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=547838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=547838"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=547838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}